Citigroup’s Wellgistics Health WGRX Stock Holding History

Citigroup’s Portfolio WGRX Stock Details WGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-152	Closed	-$3.03K	–	6511
2025 Q4	$3.03K	Buy	152 +107	+238%	+$3.14K	﹤0.01%	5377
2025 Q3	$2K	Buy	+45	New	+$2.38K	﹤0.01%	5482

Other funds holding WGRX

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citigroup's WGRX Position: Q1 2026 in Review

Citigroup sold out of Wellgistics Health (WGRX) in Q1 2026, closing a stake of 152 shares — an estimated $3.03K sold.

Citigroup first reported a position in WGRX in Q3 2025 and held it in 2 quarters. The position peaked at $3.03K in Q4 2025. 13 funds tracked by Wall St. Rank hold WGRX as of Q1 2026.

Citigroup reported no remaining Wellgistics Health position as of Q1 2026 after selling out during the quarter.
Citigroup sold 152 Wellgistics Health shares in Q1 2026, an estimated $3.03K.
Citigroup first reported a position in Wellgistics Health in Q3 2025 and held it in 2 quarters.
Citigroup's Wellgistics Health position peaked at $3.03K in Q4 2025.
13 funds tracked by Wall St. Rank held Wellgistics Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.